CRWV CoreWeave, Inc.
Services-Prepackaged Software · Nasdaq · SEC CIK 1769628 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY129.6%
TTM net income YoY-229.9%
TTM EPS YoY-124.6%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin66.7%
Operating margin-0.8%
Net margin-25.6%
FCF margin-206.6%
EBITDA margin52.5%
Returns
ROE-63.9%
ROA-4.1%
ROIC (approx.)-0.8%
Asset turnover0.16x
Leverage & solvency
Liabilities / assets95.6%
Debt / equity0.00x
Current ratio0.44x
Interest coverage-0.04x
Cash quality & payout
Operating cash flow / net income-2.85x
Accruals ratio-15.6%
Payout ratio—
Capex / revenue279.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $5.13B | $1.92B |
| Cost of revenue | $1.45B | $493.00M |
| Gross profit | $3.68B | $1.42B |
| R&D expense | $352.00M | $56.00M |
| SG&A expense | $651.00M | $119.00M |
| Operating income | -$46.00M | $324.00M |
| Interest expense | $1.15B | $349.00M |
| Pretax income | -$1.22B | -$744.00M |
| Income tax | -$48.00M | $119.00M |
| Net income | -$1.17B | -$863.00M |
| EBITDA | $2.41B | $1.19B |
| EPS (basic) | -2.75 | -4.30 |
| EPS (diluted) | -2.81 | -4.30 |
| Dividends declared per share | 0.00 | 0.00 |
| Weighted avg. shares (diluted) | 436.00M | 218.00M |
| Balance sheet | ||
| Cash & equivalents | $3.13B | $2.04B |
| Short-term investments | $34.00M | $0 |
| Receivables | $3.17B | $417.00M |
| Current assets | $7.49B | $1.92B |
| PP&E, net | $30.56B | $11.91B |
| Goodwill | $1.10B | $20.00M |
| Intangibles | $235.00M | $5.00M |
| Total assets | $49.30B | $17.83B |
| Current liabilities | $16.44B | $4.96B |
| Short-term debt | $6.71B | $2.47B |
| Long-term debt | $14.66B | $5.46B |
| Total debt | $21.37B | $7.93B |
| Total liabilities | $45.97B | $16.52B |
| Shareholders' equity | $3.33B | -$414.00M |
| Net debt | $18.25B | $5.89B |
| Cash flow statement | ||
| Operating cash flow | $3.06B | $2.75B |
| Capital expenditure | $10.31B | $8.70B |
| Free cash flow | -$7.25B | -$5.95B |
| Investing cash flow | -$10.27B | -$8.66B |
| Financing cash flow | $9.31B | $7.46B |
| Depreciation & amortization | $2.45B | $863.00M |
| Stock-based compensation | $630.00M | $31.00M |
Free plan shows the latest 2 periods; Pro shows all 3 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.